RS20080118A - Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) - Google Patents
Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)Info
- Publication number
- RS20080118A RS20080118A RSP-2008/0118A RSP20080118A RS20080118A RS 20080118 A RS20080118 A RS 20080118A RS P20080118 A RSP20080118 A RS P20080118A RS 20080118 A RS20080118 A RS 20080118A
- Authority
- RS
- Serbia
- Prior art keywords
- pyridinaminosulfonyl
- cyp3a4
- cytochrome
- inhibitors
- substituted benzamides
- Prior art date
Links
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 title 2
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 title 2
- 229940054066 benzamide antipsychotics Drugs 0.000 title 1
- 150000003936 benzamides Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Predmetni pronalazak obezbeđuje jedinjenja formule (I), ili njihove farmaceutski prihvatljive soli ili solvate, postupke za njihovo dobijanje, postupke za njihovu primenu, i farmaceutske kompozicije koje ih sadrže.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72015105P | 2005-09-23 | 2005-09-23 | |
US72311505P | 2005-10-03 | 2005-10-03 | |
US72546905P | 2005-10-11 | 2005-10-11 | |
US76225606P | 2006-01-25 | 2006-01-25 | |
US82166406P | 2006-08-07 | 2006-08-07 | |
PCT/IB2006/002639 WO2007034312A2 (en) | 2005-09-23 | 2006-09-11 | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20080118A true RS20080118A (en) | 2009-05-06 |
Family
ID=37889174
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2010/0237A RS51349B (sr) | 2005-09-23 | 2006-09-11 | Piridinaminosulfonil supstituisani benzamidi kao inhibitori citohroma p450 3a4 (cyp3a4) |
RSP-2008/0118A RS20080118A (en) | 2005-09-23 | 2006-09-11 | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2010/0237A RS51349B (sr) | 2005-09-23 | 2006-09-11 | Piridinaminosulfonil supstituisani benzamidi kao inhibitori citohroma p450 3a4 (cyp3a4) |
Country Status (29)
Country | Link |
---|---|
US (1) | US7868026B2 (sr) |
EP (1) | EP1937639B1 (sr) |
JP (1) | JP4336738B2 (sr) |
KR (1) | KR100975448B1 (sr) |
CN (1) | CN101287708B (sr) |
AT (1) | ATE459603T1 (sr) |
AU (1) | AU2006293605B2 (sr) |
BR (1) | BRPI0616156A2 (sr) |
CA (1) | CA2621805C (sr) |
CY (1) | CY1110010T1 (sr) |
DE (1) | DE602006012713D1 (sr) |
DK (1) | DK1937639T3 (sr) |
EA (1) | EA014329B1 (sr) |
EC (1) | ECSP088296A (sr) |
ES (1) | ES2340200T3 (sr) |
GE (1) | GEP20115230B (sr) |
HK (1) | HK1120506A1 (sr) |
HR (1) | HRP20100272T2 (sr) |
IL (1) | IL189666A (sr) |
MA (1) | MA29791B1 (sr) |
MY (1) | MY143391A (sr) |
NO (1) | NO20081844L (sr) |
NZ (1) | NZ566136A (sr) |
PL (1) | PL1937639T3 (sr) |
PT (1) | PT1937639E (sr) |
RS (2) | RS51349B (sr) |
SI (1) | SI1937639T1 (sr) |
TN (1) | TNSN08139A1 (sr) |
WO (1) | WO2007034312A2 (sr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008004096A1 (en) * | 2006-07-05 | 2008-01-10 | Pfizer Products Inc. | Pyrazole derivatives as cytochrome p450 inhibitors |
EP2121580A2 (en) * | 2006-12-26 | 2009-11-25 | Amgen Inc. | N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
CN101669030B (zh) | 2007-03-08 | 2016-01-13 | 小利兰·斯坦福大学托管委员会 | 线粒体醛脱氢酶2调节剂和其使用方法 |
MX2010003155A (es) * | 2007-10-04 | 2010-04-01 | Hoffmann La Roche | Derivados de ciclopropil aril amida y uso de los mismos. |
WO2010028175A1 (en) | 2008-09-08 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
EP2349279A4 (en) | 2008-10-28 | 2013-12-25 | Univ Leland Stanford Junior | ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF |
HUE025013T2 (hu) | 2009-01-12 | 2016-04-28 | Pfizer Ltd | Szulfonamid-származékok |
EP2424517A4 (en) * | 2009-05-01 | 2013-01-23 | Raqualia Pharma Inc | SULFAMOYLBENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS |
CA2804173C (en) | 2010-07-09 | 2015-01-13 | Pfizer Limited | Sulfonamide nav1.7 inhibitors |
US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
WO2014000178A1 (en) * | 2012-06-27 | 2014-01-03 | Merck Sharp & Dohme Corp. | Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
CN104540813A (zh) * | 2012-06-27 | 2015-04-22 | 默沙东公司 | 磺酰胺衍生物以及使用它们用于改善药物的药物动力学的方法 |
KR20150135332A (ko) | 2013-03-14 | 2015-12-02 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법 |
TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
WO2015070366A1 (en) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
WO2015070367A1 (en) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
PL3122750T3 (pl) | 2014-03-26 | 2020-03-31 | F.Hoffmann-La Roche Ag | Związki bicykliczne jako inhibitory wytwarzania autotaksyny (ATX) i kwasu lizofosfatydowego (LPA) |
WO2016101118A1 (en) * | 2014-12-23 | 2016-06-30 | Merck Sharp & Dohme Corp. | Amidoethyl azole orexin receptor antagonists |
WO2017037146A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169763B2 (en) * | 2002-02-22 | 2007-01-30 | Oliver Yoa-Pu Hu | Cytochrome P450 3A inhibitors and enhancers |
-
2006
- 2006-09-11 AT AT06795544T patent/ATE459603T1/de active
- 2006-09-11 WO PCT/IB2006/002639 patent/WO2007034312A2/en active Application Filing
- 2006-09-11 CA CA2621805A patent/CA2621805C/en not_active Expired - Fee Related
- 2006-09-11 EA EA200800542A patent/EA014329B1/ru not_active IP Right Cessation
- 2006-09-11 NZ NZ566136A patent/NZ566136A/en not_active IP Right Cessation
- 2006-09-11 DE DE602006012713T patent/DE602006012713D1/de active Active
- 2006-09-11 GE GEAP200610575A patent/GEP20115230B/en unknown
- 2006-09-11 AU AU2006293605A patent/AU2006293605B2/en not_active Ceased
- 2006-09-11 RS RSP-2010/0237A patent/RS51349B/sr unknown
- 2006-09-11 EP EP06795544A patent/EP1937639B1/en active Active
- 2006-09-11 DK DK06795544.3T patent/DK1937639T3/da active
- 2006-09-11 RS RSP-2008/0118A patent/RS20080118A/sr unknown
- 2006-09-11 BR BRPI0616156-1A patent/BRPI0616156A2/pt not_active IP Right Cessation
- 2006-09-11 PL PL06795544T patent/PL1937639T3/pl unknown
- 2006-09-11 KR KR1020087006967A patent/KR100975448B1/ko not_active IP Right Cessation
- 2006-09-11 SI SI200630666T patent/SI1937639T1/sl unknown
- 2006-09-11 PT PT06795544T patent/PT1937639E/pt unknown
- 2006-09-11 ES ES06795544T patent/ES2340200T3/es active Active
- 2006-09-11 CN CN2006800348278A patent/CN101287708B/zh not_active Expired - Fee Related
- 2006-09-11 JP JP2008531812A patent/JP4336738B2/ja not_active Expired - Fee Related
-
2007
- 2007-01-09 US US11/621,410 patent/US7868026B2/en not_active Expired - Fee Related
-
2008
- 2008-02-21 IL IL189666A patent/IL189666A/en not_active IP Right Cessation
- 2008-03-19 EC EC2008008296A patent/ECSP088296A/es unknown
- 2008-03-19 MA MA30764A patent/MA29791B1/fr unknown
- 2008-03-19 TN TNP2008000139A patent/TNSN08139A1/fr unknown
- 2008-03-21 MY MYPI20080779A patent/MY143391A/en unknown
- 2008-04-16 NO NO20081844A patent/NO20081844L/no not_active Application Discontinuation
- 2008-12-15 HK HK08113572.1A patent/HK1120506A1/xx not_active IP Right Cessation
-
2010
- 2010-04-20 CY CY20101100359T patent/CY1110010T1/el unknown
- 2010-05-14 HR HR20100272T patent/HRP20100272T2/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL189666A0 (en) | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) | |
NO2023022I1 (no) | cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate | |
MX2009000482A (es) | Compuestos terapeuticos. | |
WO2007087548A3 (en) | Chemical compounds | |
NO20081554L (no) | Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav | |
TW200613243A (en) | Novel compounds | |
UA96277C2 (en) | Benzimidazole derivatives | |
TW200639156A (en) | New compounds | |
WO2008004100A9 (en) | Therapeutic compounds | |
WO2008039894A3 (en) | Atorvastatin pharmaceutical compositions | |
WO2008011539A3 (en) | Anesthetic compounds | |
UA95250C2 (ru) | Пиридинаминосульфонил-замещенные бензамиды как ингибиторы цитохром р450 3а4 (cyp4503a4) | |
UA94759C2 (ru) | Производные пиразола как ингибиторы цитохрома p450 | |
TW200716530A (en) | New compounds I | |
UA96742C2 (en) | Mek inhibitors and use thereof |